On March 17, 2026, Serina Therapeutics, Inc. completed a $15 million securities private placement at $2.25 per share, simultaneously appointing Greg Bailey as Co-Chairman of the Board. The placement includes redeemable warrants with a $5 exercise price, set to fund additional amounts totaling up to $15 million within 20 days after the initial closing.